Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03185975 · ClinicalTrials.gov registry record · NA

Providing Online Counseling for Home-Based HIV Testing With Transgender Youth

A NA study of HIV and Transgender Youth, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT03185975: Completed NA study of HIV and Transgender Youth, sponsored by University of Michigan.

NCT03185975 is a NA study of HIV and Transgender Youth that has completed, run by University of Michigan. The registered enrollment target is 200 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03185975, a NA study of HIV and Transgender Youth, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

This research study will recruit 200 transgender youths between the ages of 15-24. There are two arms to the research study: the control and the intervention arm. Each eligible participant will be randomized into either arm. The control arm participants receive an OraQuick HIV testing kit sent to an address of their choice and instructions of how to conduct the test. They will enter their results on the research study website and complete surveys at 3 month intervals until an entire year has passed. Participants in the intervention arm will receive an OraQuick HIV testing kit sent to them and will receive video-based counseling called Motivational Interviewing and Certified Testing and Referral. After this counseling session, the results from the OraQuick HIV test will be logged by study staff. Then, participants in the intervention arm will fill out surveys at 3 month intervals until a year has passed.

Primary Outcome

Assess differences and changes in TY's sexual-risk behaviors between those who receive the home-testing with video-based MI/CTR (intervention arm) compared to those who receive the home-testing alone (control arm). 200 TY (100 male: 100 female) will be randomized to either the intervention or control arm and followed for 6 months with surveys taken at baselines and months 3, 6, 9 and 12 months.

Conditions Studied

Interventions

  • BEHAVIORAL at-home test kit
  • BEHAVIORAL Motivational Interviewing and Certified Testing and Referral

Study Locations (1)

Michigan

  • University of Michigan Center for Sexuality and Health Disparities - Ann Arbor

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2017-06-19
Est. Completion 2019-09-30
Phase NA
University of Michigan

1,327 total trials

What the finished NCT03185975 record still lists

NCT03185975 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (54% lower).

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which at-home test kit is the first listed.

NCT03185975 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT03185975 about?

NCT03185975 is a clinical study titled "Providing Online Counseling for Home-Based HIV Testing With Transgender Youth". This research study will recruit 200 transgender youths between the ages of 15-24. There are two arms to the research study: the control and the intervention arm. Each eligible participant will be randomized into either arm. The control arm participants receive an OraQuick HIV testing kit sent to an...

What is the current status of trial NCT03185975?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2017-06-19. Estimated completion is 2019-09-30.

What conditions does trial NCT03185975 study?

This clinical trial studies the following conditions: HIV, Transgender Youth.

What interventions are being tested in trial NCT03185975?

The interventions under investigation include: at-home test kit (BEHAVIORAL), Motivational Interviewing and Certified Testing and Referral (BEHAVIORAL).

Who is sponsoring clinical trial NCT03185975?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03185975 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03185975's enrollment target sits among peer trials

200 103rd of 303 higher than 188 of 303 other HIV trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03185975, the US trial registry maintained by the National Library of Medicine. NCT03185975 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.